康美药业
(600518)
| 流通市值：302.21亿 | | | 总市值：307.78亿 |
| 流通股本：136.13亿 | | | 总股本：138.64亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 773,508,915.68 | 794,968,788.99 | 744,682,634.9 | 1,056,606,687.63 |
| 应收票据及应收账款 | 2,313,965,965.38 | 2,234,675,989.02 | 2,199,356,111.48 | 2,078,600,814.18 |
| 其中：应收票据 | 58,610,619.91 | 60,213,930.17 | 54,950,900.44 | 49,462,247.98 |
| 应收账款 | 2,255,355,345.47 | 2,174,462,058.85 | 2,144,405,211.04 | 2,029,138,566.2 |
| 应收款项融资 | 26,285,582.31 | 26,816,947.45 | 12,294,501.23 | 16,298,325.82 |
| 预付款项 | 116,852,305.37 | 131,173,606.03 | 156,871,356.94 | 117,925,253.53 |
| 其他应收款合计 | 690,112,054.54 | 722,905,714.98 | 738,347,209.56 | 709,235,148.94 |
| 存货 | 2,885,879,627.37 | 2,886,652,286.86 | 2,805,834,949.58 | 2,643,749,272.32 |
| 其他流动资产 | 203,077,541.86 | 196,684,955.9 | 197,588,605.64 | 187,252,039 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 7,009,764,400.19 | 6,993,951,049.57 | 6,855,052,913.81 | 6,809,750,344.49 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 1,156,164.06 | 1,121,791.73 | 1,131,417.3 | 1,152,094.17 |
| 投资性房地产 | 2,707,598,535.8 | 2,757,817,060.84 | 2,783,895,558.37 | 2,807,220,584.85 |
| 固定资产 | 3,355,658,629.01 | 3,370,628,870.26 | 3,409,049,121.7 | 3,446,204,102.72 |
| 在建工程 | 172,773,268.61 | 172,641,370.06 | 173,167,480.03 | 210,564,383.82 |
| 生产性生物资产 | 658,453.75 | 679,622.32 | 700,790.89 | 721,959.46 |
| 使用权资产 | 182,153,238.22 | 193,568,851.32 | 211,458,013.4 | 217,544,027.27 |
| 无形资产 | 465,119,525.13 | 469,980,786.35 | 474,157,206.34 | 491,023,308.91 |
| 商誉 | 106,350,551.22 | 106,350,551.22 | 106,350,551.22 | 106,350,551.22 |
| 长期待摊费用 | 61,208,617.56 | 61,479,157.16 | 64,440,126.06 | 66,466,445.96 |
| 递延所得税资产 | 97,534,786.89 | 100,404,166.92 | 102,372,874.83 | 101,484,637.16 |
| 其他非流动资产 | 33,630,471.37 | 28,381,154.91 | 23,430,785.58 | 21,896,524.84 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 7,183,842,241.62 | 7,263,053,383.09 | 7,350,153,925.72 | 7,470,628,620.38 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 14,193,606,641.81 | 14,257,004,432.66 | 14,205,206,839.53 | 14,280,378,964.87 |
| 流动负债: | | | | |
| 短期借款 | 12,202,364.42 | 23,410,292.01 | 29,957,588.33 | 26,136,585.09 |
| 应付票据及应付账款 | 2,543,103,864.13 | 2,523,347,411.14 | 2,407,894,771.47 | 2,256,391,867.53 |
| 其中：应付票据 | 37,784,826.4 | 89,963,387.77 | 89,885,202.46 | 51,330,441.35 |
| 应付账款 | 2,505,319,037.73 | 2,433,384,023.37 | 2,318,009,569.01 | 2,205,061,426.18 |
| 预收款项 | 39,957,268.78 | 45,293,718.8 | 40,551,627.29 | 58,652,718.27 |
| 合同负债 | 172,840,915.39 | 151,909,962.74 | 143,822,509.81 | 159,889,284.32 |
| 应付职工薪酬 | 62,643,489.33 | 59,351,301.44 | 67,827,954.48 | 76,479,530.02 |
| 应交税费 | 410,537,678.66 | 405,331,817.25 | 406,876,194.15 | 571,299,467.82 |
| 其他应付款合计 | 1,548,104,538.88 | 1,372,422,806.77 | 1,409,944,581.16 | 1,404,578,328.31 |
| 应付股利 | 2,500,000 | - | - | - |
| 一年内到期的非流动负债 | 34,535,911.14 | 36,281,399.28 | 39,402,933.03 | 40,713,994.96 |
| 其他流动负债 | 86,592,203.16 | 84,758,811.86 | 83,404,229.59 | 85,879,305.45 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 4,910,518,233.89 | 4,702,107,521.29 | 4,629,682,389.31 | 4,680,021,081.77 |
| 非流动负债: | | | | |
| 租赁负债 | 169,194,273.14 | 176,455,875.14 | 186,615,317.56 | 188,163,023.45 |
| 长期应付款 | 780,893,989.54 | 805,122,692.05 | 805,639,284.69 | 805,833,312.69 |
| 预计负债 | 621,497,764.42 | 823,826,802.63 | 832,443,512.98 | 855,544,652.74 |
| 递延收益 | 591,848,499.35 | 603,416,654.48 | 610,899,053.81 | 618,682,597.76 |
| 递延所得税负债 | 43,853,546.01 | 46,433,814.93 | 50,655,433.57 | 51,682,876.52 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 2,207,288,072.46 | 2,455,255,839.23 | 2,486,252,602.61 | 2,519,906,463.16 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 7,117,806,306.35 | 7,157,363,360.52 | 7,115,934,991.92 | 7,199,927,544.93 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 13,863,866,690 | 13,863,866,690 | 13,863,866,690 | 13,863,866,690 |
| 资本公积 | 18,782,890,509.57 | 18,782,890,509.57 | 18,782,890,509.57 | 18,782,890,509.57 |
| 减:库存股 | 1,235,733,713.4 | 1,224,388,047.3 | 1,225,017,640.4 | 1,225,017,640.4 |
| 其他综合收益 | -218,191.98 | -251,969.2 | -121,824.93 | -100,052.37 |
| 专项储备 | 1,405,580.76 | 1,370,111.37 | 1,207,712.26 | 1,278,328.74 |
| 盈余公积 | 1,525,575,798.27 | 1,525,575,798.27 | 1,525,575,798.27 | 1,525,575,798.27 |
| 未分配利润 | -25,895,919,100.61 | -25,885,174,312.37 | -25,893,463,329.76 | -25,900,934,638.21 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,041,867,572.61 | 7,063,888,780.34 | 7,054,937,915.01 | 7,047,558,995.6 |
| 少数股东权益 | 33,932,762.85 | 35,752,291.8 | 34,333,932.6 | 32,892,424.34 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,075,800,335.46 | 7,099,641,072.14 | 7,089,271,847.61 | 7,080,451,419.94 |
| 负债和股东权益合计 | 14,193,606,641.81 | 14,257,004,432.66 | 14,205,206,839.53 | 14,280,378,964.87 |
| 公告日期 | 2024-10-31 | 2024-08-24 | 2024-04-30 | 2024-04-13 |
| 审计意见(境内) | | | | 标准无保留意见 |